Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

21.40
Delayed Data
As of Feb 12
 -0.04 / -0.19%
Today’s Change
20.48
Today|||52-Week Range
77.73
-29.12%
Year-to-Date
No recent news for AMAG Pharmaceuticals Inc.

Today’s Trading

Previous close21.44
Today’s open21.55
Day’s range20.48 - 21.74
Volume1,257,606
Average volume (3 months)1,192,642
Market cap$742.7M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-80.01%
Earnings growth (next 5 years)+239.42%
Revenue growth (last year)+53.83%
P/E ratio4.4
Price/Sales8.64
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
ALRPRBAlere Inc+0.05+0.01%
VIVOMeridian Bioscience ...+0.21+1.08%
GHDXGenomic Health Inc+0.72+2.79%
AAAPAdvanced Accelerator...+0.47+1.92%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)$0.30
Annual revenue (last year)$124.4M
Annual profit (last year)$135.8M
Net profit margin109.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President, COO, CFO &
CAO
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers